Psychiatric Times
CONTINUE TO SITE

OR WAIT null SECS

Psychiatric Times
Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
Topics
Media
Publications
Job BoardCME/CEPartners
Resources
Subscribe

  • Contact Us
  • Editorial
  • Terms and Conditions
  • Privacy Policy
  • Do Not Sell My Personal Information
  • MJHLS Brand Logo

© 2022 MJH Life Sciences and Psychiatric Times. All rights reserved.

SpotlightSee All >
  • Psychedelics
  • ADHD
  • APA Conference Insider
  • Case Discussion with Dr. Simmons-Becil: Bipolar Disorder
  • Correctional Health Care in California
  • Major Depressive Disorder
  • Navigating Narcolepsy: Excessive Daytime Sleepiness
CommentarySee All >
  • Couch In Crisis
  • Early Career Psychiatry
  • History of Psychiatry
  • Residents Corner
Cultural CornerSee All >
  • Film and Book Reviews
  • Poetry
  • Writers Contest
Psychiatric PracticeSee All >
  • Burnout
  • Careers
  • Coding
  • Guidelines
  • Risk Management
  • Telepsychiatry
SeriesSee All >
  • Climate Change
  • Critical Conversations in Psychiatry
  • Portraits
  • Psychiatric Views on the Daily News
  • Tales From the Clinic: The Art of Psychiatry
  • Tales from the New Asylum
  • Contact Us
  • Editorial
  • Terms and Conditions
  • Privacy Policy
  • Do Not Sell My Personal Information
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and Psychiatric Times. All rights reserved.

Once-Nightly Sodium Oxybate for Narcolepsy

A journal club review of “Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in phase 3 randomized clinical trial in patients with narcolepsy,” by Kushida CA, et al.

EP1: Presentation: Improvement of Narcolepsy Symptoms with Once-Nightly Sodium Oxybate

December 22nd 2021

Sponsored by: Avadel

Dr Clete Kushida discusses the results of a phase 3 clinical trial that examined once-nightly sodium oxybate in patients with narcolepsy.

EP2: Key Takeaways and Management of Narcolepsy

January 5th 2022

Sponsored by: Avadel

Takeaways of the REST-ON clinical trial results as presented in Sleep that help clinicians learn more about the management of patients with narcolepsy.

EP3: Questions Regarding Once-Nightly Sodium Oxybate for Narcolepsy

January 12th 2022

Sponsored by: Avadel

Questions raised by a recent paper by Kushida CA, et al., highlighting symptom improvement with once-nightly sodium oxybate in patients with narcolepsy.

EP4: Adopting Once-Nightly Sodium Oxybate into Clinical Practice to Treat Narcolepsy

January 19th 2022

Sponsored by: Avadel

The potential benefits of integrating once-nightly sodium oxybate into routine clinical practice to help address treatment limitations for patients with narcolepsy.

EP5: Future Opportunities Using One-Nightly Sodium Oxybate for Narcolepsy Treatment

January 26th 2022

Sponsored by: Avadel

Important next steps studying once-nightly sodium oxybate and other therapies for narcolepsy treatment.